RePORT ⟩ RePORTER

Skip Navigation Links

Search Results

Project Details

ComPASS Collective for Community Engagement (C3E)

Project Number3UL1TR002243-07S1

Former Number5UL1TR002243-07

Contact PI/Project LeaderSELF, WESLEY H
Other PIs

Awardee OrganizationVANDERBILT UNIVERSITY MEDICAL CENTER

Description

Abstract Text

The Vanderbilt Institute for Clinical and Translational Research (VICTR) is a highly functional and integrated clinical and translational (C&T) research infrastructure that has raised the quality and scientific rigor of the research conducted at Vanderbilt and longstanding partner Meharry, the nation's oldest historically black academic health science institution. VICTR will contribute to the mission of the CTSA program while leveraging unique resources and expertise within VICTR's Hub and elevating the role of health equity in C&T research with these new aims: 1) Leverage VICTR's strong collaborative energy to enhance team science methodologies, integrate community engagement principles for all stages of research, and implement programs designed to support health equity in research; 2) Develop and share multi-dimensional data organization methods and informatics tools to promulgate innovation, efficiency, quality, and equity in research; 3) Ensure the translational science workforce is diverse and has the skills, knowledge, and resources necessary to advance translation of discoveries within a health equity framework; 4) Support the efficiency, quality, representativeness, and impact of local studies and `raise the bar' for acceptable scientific standards in research conduct; 5) Support the efficiency, quality, representativeness, and impact of multi-site clinical trials by building and disseminating streamlining programs and promoting novel trial designs; and 6) Utilize unique institutional capabilities to enable the conduct of pragmatic trials during healthcare operations and repurpose existing drugs for new indications.

Public Health Relevance Statement

The ComPASS Collective for Community Engagement (C3E) aims to catalyze NIH-funded community- driven and community-engaged research by developing and disseminating publicly available resources with tools, and best practices to enable communities to fully participate in health equity research. The overarching goal of C3E is to create a roadmap for sustainable engagement of communities in health equity research. ComPASS Collective for Community Engagement (C3E); Wilkins CH; 7.13.2023

NIH Spending Category

Clinical Research Health Disparities Research Health Disparities and Racial or Ethnic Minority Health Research Social Determinants of Health

Project Terms

AcademyAddressApplications GrantsArchivesAreaAutomobile DrivingBiomedical ResearchCOVID-19Chronic DiseaseClinical ResearchClinical and Translational Science AwardsCommunitiesCommunity DevelopmentsComplexDataEnsureEquityExclusionFoundationsFundingFutureGoalsHealth SciencesHealthcareHybridsInfrastructureInstitutionInternetInterventionKnowledgeMeasuresMedicineMethodologyMethodsMinority-Serving InstitutionMissionModelingMulti-Institutional Clinical TrialNational Center for Advancing Translational SciencesNational Institute on Minority Health and Health DisparitiesNeeds AssessmentPatient-Focused OutcomesPharmaceutical PreparationsPoliciesPublic Health InformaticsRADxRecommendationResearchResearch InfrastructureResearch InstituteResearch PersonnelResource DevelopmentResourcesReview LiteratureRoleScienceSeriesSummary ReportsSystemTranslational ResearchTranslationsUnited States National Institutes of HealthVoicecommunity based participatory researchcommunity engaged researchcommunity engagementcommunity organizationscommunity partnershipdesignhealth equityhealth inequalitiesimprovedinformatics toolinnovationmarginalizationmarginalized populationmeetingsmultidimensional datanoveloperationpragmatic trialpreventprogramsresponsescience and societyskillssuccesstooltrial design

Details

Contact PI/ Project Leader

Name

SELF, WESLEY H

Title

PROFESSOR / SENIOR VICE PRESIDENT

Contact

Other PIs

Name

BERNARD, GORDON RAPHAEL WILKINS, CONSUELO HOPKINS

Program Official

Name

GOPAL-SRIVASTAVA, RASHMI

Contact

Organization

Name

VANDERBILT UNIVERSITY MEDICAL CENTER

City

NASHVILLE

Country

UNITED STATES (US)

Department Type

Unavailable

Organization Type

Independent Hospitals

State Code

Congressional District

Other Information

Opportunity Number

PA-20-272

Study Section

Fiscal Year

2023

Award Notice Date

11-September-2023

Administering Institutes or Centers

National Center for Advancing Translational Sciences

CFDA Code

350

DUNS Number

079917897

UEI

GYLUH9UXHDX5

Project Start Date

11-September-2023

Project End Date

29-February-2024

Budget Start Date

11-September-2023

Budget End Date

29-February-2024

Project Funding Information for 2023

Total Funding

$700,000

Direct Costs

$400,000

Indirect Costs

$300,000

Year	Funding IC	FY Total Cost by IC
2023	NIH Office of the Director	$700,000

NIH Categorical SpendingClick here for more information on NIH Categorical Spending

Funding IC	FY Total Cost by IC	NIH Spending Category
RMAP	$700,000	Clinical Research; Health Disparities Research; Health Disparities and Racial or Ethnic Minority Health Research; Social Determinants of Health

Sub Projects

No Sub Projects information available for 3UL1TR002243-07S1

Publications

Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.

No Publications available for 3UL1TR002243-07S1

Patents

No Patents information available for 3UL1TR002243-07S1

Outcomes

The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.

No Outcomes available for 3UL1TR002243-07S1

Clinical Studies

No Clinical Studies information available for 3UL1TR002243-07S1

News and More

Section Menu